Access to High-Cost Medications After a Cap on Monthly Out-of-Pocket Spending in California

Published in: JAMA Network Open, Volume 4, No. 9 (September 2021). doi: 10.1001/jamanetworkopen.2021.26642

Posted on on March 04, 2022

by Erin Audrey Taylor, Christine Buttorff, Vishaal Pegany, Lindsay Petersen, Allison Mangiaracino, Emory Wolf, Lance Lang

Read More

Access further information on this document at JAMA Network Open

This article was published outside of RAND. The full text of the article can be found at the link above.

High prescription drug costs are a substantial problem for many patients who cannot afford their medications, even with health insurance. Capping monthly out-of-pocket (OOP) costs for high-cost drugs may increase the affordability of these medications. In January 2016, Covered California implemented a monthly cap on OOP costs for high-cost drugs to increase patient access. We evaluated the association of this cap with high-cost drug use and OOP spending.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.